Latest filing published 28 Jun 2018 for TG Therapeutics, INC..
Insider track record
No signal scores available.
Mark Schoenebaum: trading record in brief
Mark Schoenebaum discloses dealings in TG Therapeutics, Inc. to SEC (Form 4). Between 16 May 2012 and 26 June 2018, the trades on record add up to 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 28 June 2018 with a share grant in TG Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Schoenebaum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares0COMMON STOCKSEC:0001654954-18-007117:0
- 15,000 shares0COMMON STOCKSEC:0001654954-17-005703:0
- 12,459 shares0COMMON STOCKSEC:0001144204-16-112313:0
- 4,667 shares0COMMON STOCKSEC:0001144204-15-035880:0
- 11,538 shares0COMMON STOCKSEC:0001144204-14-036690:0
- 8,404 shares0COMMON STOCKSEC:0001144204-13-033953:0
- 8,881 shares0COMMON STOCKSEC:0001144204-13-016160:0
- 50,000 shares0COMMON STOCKSEC:0001144204-12-030409:0
8 of 8 declarations